Herein we describe the discovery and validation of the combined expression of two protein biomarkers, AMBRA1 and loricrin, in the epidermis overlying primary AJCC stage I melanomas as a highly sensitive and specific prognostic biomarker. Here, LORICRIN is linked to melanoma.